Adicet Bio Inc (ACET)
1.47
-0.17
(-10.37%)
USD |
NASDAQ |
May 10, 16:00
1.46
-0.01
(-0.68%)
After-Hours: 20:00
Adicet Bio Cash from Investing (TTM): -4.464M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -4.464M |
September 30, 2023 | -10.82M |
June 30, 2023 | -14.72M |
March 31, 2023 | -16.06M |
December 31, 2022 | -16.78M |
September 30, 2022 | -13.37M |
June 30, 2022 | -15.74M |
Date | Value |
---|---|
March 31, 2022 | -13.27M |
December 31, 2021 | -2.796M |
September 30, 2021 | 12.73M |
June 30, 2021 | 94.55M |
March 31, 2021 | 118.61M |
December 31, 2020 | 115.22M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-16.78M
Minimum
Dec 2022
118.61M
Maximum
Mar 2021
17.93M
Average
-10.82M
Median
Sep 2023
Cash from Investing (TTM) Benchmarks
Catalyst Pharmaceuticals Inc | -131.33M |
Codexis Inc | -30.14M |
Annexon Inc | 70.70M |
Taysha Gene Therapies Inc | -7.352M |
Praxis Precision Medicines Inc | 38.95M |